Boston Scientific
Trade Boston Scientific 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BSX
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
BSX Key Statistics
Stock Snapshot
As of today, Boston Scientific(BSX) shares are valued at $65.74. The company's market cap stands at 106.49B, with a P/E ratio of 31.45.
During the trading session on 2026-04-23, Boston Scientific(BSX) shares reached a daily high of $66.88 and a low of $64.81. At a current price of $65.74, the stock is +1.4% higher than the low and still -1.7% under the high.
Trading activity shows a volume of 23.75M, compared to an average daily volume of 17.06M.
Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $59.39.
Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $59.39.
BSX News
RBC Capital lowered the firm’s price target on Boston Scientific (BSX) to $100 from $105 and keeps an Outperform rating on the shares. The stock rose after the...
Boston Scientific Corporation (NYSE:BSX) reported upbeat earnings for the first quarter on Wednesday. The company posted first-quarter 2026 revenues of $5.20 b...
AST SpaceMobile, Inc. ( ASTS ) shares rose 5.8% after securing Federal Communications Commission approval for its satellite-based cellular broadband plan. ASTS...
Analyst ratings
97%
of 37 ratingsMore BSX News
Boston Scientific ((BSX)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 30% Off TipRanks Unlock hedge fund-level data and po...
Q1 2026, Boston Scientific (NYSE:BSX) reported positive clinical trial results for the WATCHMAN FLX Left Atrial Appendage Closure Device and the EKOS Endovascul...
Boston Scientific (NYSE:BSX), a medical device developer, closed Wednesday at $64.87, up 8.99%. The stock is jumping after a Q1 earnings beat paired with lowere...
Michael Matson, an analyst from Needham, maintained the Buy rating on Boston Scientific. The associated price target was lowered to $77.00. Unlock hedge fund-l...
Analyst Josh Jennings of TD Cowen maintained a Buy rating on Boston Scientific, reducing the price target to $80.00. Claim 30% Off TipRanks Unlock hedge fund-le...
Sales increased 11.6% on a reported basis, within the company’s guidance range of 10.5%-12%, and 9.4% on an operational and organic basis, within the company’s...
The stock of Boston Scientific (BSX) is up 10% on April 22 after the medical device maker issued financial results that topped Wall Street’s forecasts. Claim 30...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.